BIOTRICITY INC. (BTCY) Financial Statements

BIOTRICITY INC. (BTCY) files with the U.S. Securities and Exchange Commission under CIK 0001630113. 10KGenie shows its annual and quarterly statements from SEC filings.

Key Figures, Fiscal Year 2026

Revenue
$16.00 million
Net Income
-$2.40 million
Total Assets
$6.45 million
Net Cash from Operations
-$718.96 thousand

Fiscal year ended Mar 31, 2026. Latest periodic SEC filing: Aug 19, 2026. Source: SEC filings (EDGAR XBRL).

Open the full financial statements for BTCY in 10KGenie

Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History